Senior Portfolio Marketing Director
Protecting pharmaceutical innovations from counterfeit attacks
Clarivate Analytics recently released its Cortellis Drugs to Watch 2019 report, which analyzed seven drugs set to enter the market this year and achieve "blockbuster" status ($1 billion in annual sales) by 2023. Blockbuster drugs face great market potential and are often a “make or break” for some pharmaceutical companies, especially those with a limited drug pipeline or small portfolio. As with any new product, they can face an onslaught of competitive challenges in the market, but the one competitor that must not be forgotten is the threat posed by counterfeiters. The pharma industry is one of the most regulated sectors in the... Read More

Search

Follow Us

Get all the latest updates

Subscribe
Get all the latest updates
Interests

Featured Author

Stefanie Ellis
Stefanie has over ten years’ experience in anti-fraud, brand protection and vendor relations, she has worked with a wi... More

US (800) 745 9229

|

Global +1 (628) 256 7175

|

Europe +44 (0) 1978 528 370

All Contact Information

Search WHOIS